201
Views
6
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains

, , , , , & show all

References

  • Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al, Global antifungal surveillance group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366–1377.
  • Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–163.
  • Csank C, Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett. 2000;189:115–120.10.1111/fml.2000.189.issue-1
  • Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12:80–96.
  • Chapeland-Leclerc F, Hennequin C, Papon N, Noël T, Girard A, Socié G, et al. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob Agents Chemother. 2010;54:1360–1362.10.1128/AAC.01138-09
  • Pfaller MA, Diekema DJ. The epidemiology of invasive candidiasis. In: Calderone RA, Clancy CJ, editors. Candida and candidiasis. 2nd ed. Washington, DC: ASM Press; 2012. p. 449–480.
  • de Groot PW, Kraneveld EA, Yin QY, Dekker HL, Gross U, Crielaard W, et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell. 2008;7:1951–1964.10.1128/EC.00284-08
  • West L, Lowman DW, Mora-Montes HM, Grubb S, Murdoch C, Thornhill MH, et al. Differential virulence of Candida glabrata Glycosylation mutants. J Biol Chem. 2013;288:22006–18.
  • Mora-Montes HM, McKenzie C, Bain JM, Lewis LE, Erwig LP, Gow NA. Interactions between macrophages and cell wall oligosaccharides of Candida albicans. Methods Mol Biol. 2012;845:247–260.
  • Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2006;2:e63.10.1371/journal.ppat.0020063
  • Calderone RA, Brown PC. Adherence and receptor relationship of Candida albicans. Microbiol Rev. 1991;55:1–20.
  • Hazen KC. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect Immun. 1989;57:1894–1900.
  • Halliwell SC, Smith MC, Muston P, Holland SL, Avery SV. Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata. Eukaryot Cell. 2012;11:141–150.10.1128/EC.05232-11
  • Castaño I, Pan SJ, Zupancic M, Hennequin C, Dujon B, Cormack BP. Telomere length control and transcriptional regulation of subtelomericadhesins in Candida glabrata. Mol Microbiol. 2005;5:246–258.
  • Domergue R, Castaño I, De Las Penãs A, Zupanic M, Lockatell V, Hebel JR. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science. 2005;308:866–870.10.1126/science.1108640
  • Iraqui I, Garcia-Sanchez S, Aubert S, Dromer F, Ghigo GM, D’Enfert G, Jambon G. The YAK1p kinase control expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol Microbiol. 2005;55:1259–1271.
  • Kucharıkova S, Tournu H, Lagrou K, Van Dijck P, Bujdakova H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol. 2011;60:1261–1269.10.1099/jmm.0.032037-0
  • Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol. 2006;9:588–594.
  • Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake HS, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol. 2009;54:1052–1060.10.1016/j.archoralbio.2009.08.002
  • Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009;47:681–689.10.3109/13693780802549594
  • Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde R, Bauser C, Bader O, Sanglard D. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 2009;5:e1000268.10.1371/journal.ppat.1000268
  • Angiolella L, Facchin M, Stringaro A, Maras B, Simonetti N, Cassone A. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptideantimycotics. J Infect Dis. 1996;173:684–690.10.1093/infdis/173.3.684
  • Panfoli I, Calzia D, Santucci L, Ravera S, Bruschi M, Candiano G. A blue dive: from ‘blue fingers’ to ‘blue silver’. A comparative overview of staining methods for in-gel proteomics. Expert Rev Proteomics. 2012;9:627–634.10.1586/epr.12.63
  • Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Meth. 2008;72:157–165.10.1016/j.mimet.2007.11.010
  • Fleet GH, Manners DJ. Isolation and composition of an alkali-soluble glucan from the cell wall of Saccharomyces cerevisiae. J. Gen. Microbiol. 1976;94:80–92.
  • Fleet GH, Manners DJ. The enzymatic degradation of an alkali-soluble glucan from the cell walls of Saccharomyces cerevisiae. J. Gen. Microbiol. 1977;98:315–327.10.1099/00221287-98-2-315
  • Dubois M, Giles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28:350–56.
  • He M, Du M, Fan M, Bian Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia. 2007;163:137–143.10.1007/s11046-007-0097-2
  • Weig M, Jansch L, Gross U, De Koster CG, Klis FM, De Groot PW. Systematic identification in silico of covalently bound cell wall proteins and analysis of protein-polysaccharide linkages of the human pathogen Candida glabrata. Microbiology. 2004;150:3129–3144.10.1099/mic.0.27256-0
  • Garcia R, Bermejo C, Grau C, Perez R, Rodriguez-Pena JM, Francois J, et al. The global transcriptional response to transient cell wall damage in Saccharomyces cerevisiae and its regulation by the cell integrity signaling pathway. J Biol Chem. 2004;279:15183–15195.
  • Kraneveld EA, de Soet JJ, Deng DM, Dekker HL, de Koster CG, Klis FM, et al. Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia. 2011;172:415–427.10.1007/s11046-011-9446-2
  • Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130–180.
  • Ying S, Chunyang L. Correlation between phospholipase of Candida albicans and resistance to fluconazole. Mycoses. 2012;55:50–55.10.1111/myc.2011.55.issue-1
  • Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000;13:122–143.10.1128/CMR.13.1.122-143.2000
  • Hamilton AJ, Holdom MD, Jeavons L. Expression of the Cu, Zn superoxide dismutase of Aspergillusfumigatus as determined by immunochemistry and immunoelectron microscopy. FEMS Immunol Med Microbiol. 1996;14:95–102.10.1111/j.1574-695X.1996.tb00275.x
  • Motshwene P, Brandt W, Lindsey G. Significant quantities of the glycolytic enzyme phosphoglycerate mutase are present in the cell wall of yeast Saccharomyces cerevisiae. Biochem J. 2003;369:357–362.10.1042/bj20021352
  • Karkowska-Kuleta J, Kedracka-Krok S, Rapala-Kozik M, Kamysz W, Bielinska S, Karafova A, Kozik A. Molecular determinants of the interaction between human high molecular weight kininogen and Candida albicans cell wall: Identification of kininogen-binding proteins on fungal cell wall and mapping the cell wall-binding regions on kininogen molecule. Peptides. 2011;32:2488–2496.10.1016/j.peptides.2011.10.021
  • Loureiro YPCV, Kubitschek PH, Larcher G, Perales J, Rodriguez Leon I, Lopes-Bezerra LM, Bouchara JP. Proteomic analysis of cytosolic proteins associated with petite mutations in Candida glabrata. Braz J Med Biol Res. 2010;43:1203–1214.10.1590/S0100-879X2010007500125
  • Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A, Watanabe N. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother. 2002;46:3113–3117.10.1128/AAC.46.10.3113-3117.2002
  • Maras B, Angiolella L, Mignogna G, Vavala E, Macone A, Colone M, et al. Glutathione metabolism in Candida albicans resistant strains to fluconazole and micafungin. PLoS One. 2014;9(6):e98387.10.1371/journal.pone.009838710.1111/j.1574-6976.2011.00278.x
  • Kyselgof G, Sandovsky-Losica H, Berdicevsky I, Segal E. Caspofungin affects adhesion of Candida to a human cell line. JMycol Med. 2007;17:1–7.
  • Frieman MB, McCaffery JM, Cormack BP. Modular domain structure in the Candida glabrataadhesin Epa1p, a β 1.6 glucan- cross-linked cell wall protein. Mol Microbiol. 2002;46:479–492.10.1046/j.1365-2958.2002.03166.x
  • Lopez CM, Wallich R, Riesbeck K, Skerka C, Zipfe PF. Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLoS One. 2014;9(3):e90796.10.1371/journal.pone.0090796
  • Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol. 2002;19:139–143.
  • Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11:30–36.10.1016/S0966-842X(02)00002-1
  • Borghi E, Sciota R, Biassoni C, Cirasola D, Cappelletti L, Vizzini L, et al. Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates. J Med Microbiol. 2011;60:689–690.
  • Angiolella L, Maras B, Stringaro AR, Arancia G, Mondello F, Girolamo A, et al. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptideantimycotic. J Chemother. 2005;17:409–416.10.1179/joc.2005.17.4.409
  • Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, Toccacieli L, et al. Increase of virulence and its phenotypic trait in drug-resistant strains of Candida albicans. Antimicrob Agents Chemoter. 2008;52:927–936.10.1128/AAC.01223-07
  • Gow NA, Brown AJ, Odds FC. Fungal morphogenesis and host invasion. Curr Opin Microbiol. 2002;5:366–371.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.